Keywords: DAA, directly acting antiviral; Glycyrrhizin; IFN, interferon; PEG-IFN-α, pegylated-interferon-alfa; SOC, standard of care; SVR, sustained virological response; hepatitis C virus; interferon alfa-2b; ribavirin; treatment.